Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish read-only/idempotent/non-destructive behavior, so the bar for added value is lower but the description still goes well beyond. It reveals multi-endpoint cascading, graceful degradation when GLEIF/OpenFIGI are unavailable, the ambiguous-match behavior (asserts nothing and returns figi_candidates), explicit unresolved identifier reporting, and how ISINs resolve to legal entities via GLEIF. This is detailed behavioral transparency.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense and front-loaded with purpose, but it is written as one long run-on passage with heavy parentheticals. Most sentences earn their place, but the structure is hard to scan and could be broken into bullets or shorter sections. It is more verbose than necessary.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description covers the critical behavioral context an agent needs: what identifiers are returned, what happens on ambiguity, what happens when enrichment sources fail, and how input values should be normalized. It is complete enough to invoke correctly and interpret non-error outcomes.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, which normally warrants a baseline 3, but the description adds substantial meaning beyond the schema. It specifies accepted input forms for both entity types, uses concrete examples, and warns against passing full noun phrases for bonds, clarifying exactly how the value parameter should be shaped.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings and states the core function: resolving a user-spoken NAME to canonical/official identifiers other tools require as input. It clearly differentiates from siblings by asserting 'Use FIRST whenever you have a name but need an ID,' which no other sibling description claims.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly tells the agent when to invoke this tool: whenever a name needs to become an ID. It also gives a clear precedence ('Use FIRST'), and contextualizes that it replaces 2–3 manual lookups. It does not name specific sibling alternatives or provide explicit when-not-to-use exclusions, but the use-case framing is strong.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools occupy the same entry-point role (ask_pipeworx, ask_pipeworx_beta, deep_research, discover_tools, suggest_questions), and ask_pipeworx_beta is explicitly identical to ask_pipeworx right now. The Polymarket family is carefully described but still has heavily overlapping discovery/edge surfaces. Only validate_json_schema is unambiguous, and it has no related siblings to clarify its position.

Naming Consistency2/5

Tool names mix verb-first forms (discover_tools, generate_llms_txt, resolve_entity), noun-first forms (entity_profile, pipeworx_feedback), and bare verbs (remember, recall, forget). Prefix conventions are inconsistent—ask_pipeworx, pipeworx_feedback, polymarket_edges, recent_changes—and almost none of the names reflect the server name Jsonschema.

Tool Count1/5

32 tools is already too many, but for a server named Jsonschema only one tool belongs to that domain; the rest form a broad data-research and prediction-market suite. This is an extreme scoping mismatch: the set is simultaneously oversized and almost entirely off-purpose.

Completeness1/5

For a JSON Schema server, the surface is essentially one operation: validate_json_schema. Common schema lifecycle operations—generation, parsing, conversion, ref resolution, linting—are missing, leaving most JSON Schema tasks impossible. The unrelated data-research tools are internally rich, but they do not complete the apparent domain.